# Gopaldas Visram & Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/gopaldas-visram-co-ltd/edccfa66-9b70-4180-bd41-727be87c0d6e

> Inspection records and compliance data for Gopaldas Visram & Co., Ltd. in Navi Mumbai, None. Access full analysis and detailed observations.

---

## Details

- Name: Gopaldas Visram & Co., Ltd.
- FEI Number: 3009565091
- City: Navi Mumbai
- State: None
- Country Name: India
- Address Line 1: Ttc Industrial Area, A327 Midc Mahape
- Zip Code: None

## Related Documents

- [483 - Gopaldas Visram & Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/483/gopaldas-visram-co-ltd/87b2355a-4d6d-4569-8611-340c1484e10a) — source: FDA, date: January 24, 2025
- [FDA Inspection 1259106 - Gopaldas Visram & Co., Ltd. - 2025-01-24](https://www.keypedia.com/records/fda_inspections/gopaldas-visram-co-ltd/608c5a85-6516-498e-a1ca-76132693d683) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2025
- [FDA Inspection 1113868 - Gopaldas Visram & Co., Ltd. - 2019-11-15](https://www.keypedia.com/records/fda_inspections/gopaldas-visram-co-ltd/386281fc-4fbe-47f7-a678-030b0aa41a8f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 15, 2019
- [FDA Inspection 1034625 - Gopaldas Visram & Co., Ltd. - 2017-12-01](https://www.keypedia.com/records/fda_inspections/gopaldas-visram-co-ltd/0e90ed84-bb28-449d-967d-45b07d3a002c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 1, 2017
- [EMA GMP - Gopaldas Visram & Co., Ltd. - MT/001NCR/2017 - 2017-08-29](https://www.keypedia.com/records/ema/gopaldas-visram-co-ltd/77a8c9b4-8e1e-4c08-9030-7a045929d441) — source: EMA, date: August 29, 2017

## Related Companies

- [Yung Shin Pharmaceutical Industry Co., Ltd.](https://www.keypedia.com/companies/yung-shin-pharmaceutical-industry-co-ltd/231493b4-19d3-4045-807b-3b0108ce15ba)
- [Greer Laboratories, Inc.](https://www.keypedia.com/companies/greer-laboratories-inc/9e93bfa2-3578-44bb-93cd-fa80496d73a5)
- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306)
- [Swiss American CDMO, LLC](https://www.keypedia.com/companies/swiss-american-cdmo-llc/a4a811fc-a442-480b-a003-b66ee374d059)
- [Formulation Technology, Inc.](https://www.keypedia.com/companies/formulation-technology-inc/38721a36-c9d0-44b1-ad0f-4dd20d8139d1)
- [PRIMROSE CANDY CO](https://www.keypedia.com/companies/primrose-candy-co/3c068e82-ef91-4264-aea2-355bc538aa3c)
- [Gemini Pharmaceuticals, Inc.](https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f)
- [Bell International Laboratories, Inc.](https://www.keypedia.com/companies/bell-international-laboratories-inc/05bfffdb-a90b-428e-afc2-35751b6cc668)
- [Blaine Labs Inc](https://www.keypedia.com/companies/blaine-labs-inc/9b08b501-8f11-452d-914e-3f5339cbed81)
- [Wasatch Product Development, LLC](https://www.keypedia.com/companies/wasatch-product-development-llc/3545661f-a68f-404a-895d-c00555648648)

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)